Cosmos Holdings CEO Makes Bold Insider Move With Fresh Share Buy
TipRanks (Fri, 9-Jan 9:01 PM ET)
Top Executive Makes Bold Move With Fresh Cosmos Holdings Stock Purchase
TipRanks (Thu, 8-Jan 9:01 PM ET)
Globe Newswire (Mon, 5-Jan 9:30 AM ET)
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
ACCESS Newswire (Wed, 24-Dec 9:00 AM ET)
Cosmos Health is Forcing the Market to Reframe the Conversation
ACCESS Newswire (Fri, 19-Dec 9:00 AM ET)
Globe Newswire (Wed, 3-Dec 12:20 PM ET)
Globe Newswire (Tue, 2-Dec 12:15 PM ET)
Globe Newswire (Mon, 17-Nov 9:15 AM ET)
Globe Newswire (Fri, 31-Oct 10:45 AM ET)
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Cosmos Health trades on the NASDAQ stock market under the symbol COSM.
As of January 13, 2026, COSM stock price climbed to $0.51 with 661,379 million shares trading.
COSM has a beta of 2.06, meaning it tends to be more sensitive to market movements. COSM has a correlation of 0.12 to the broad based SPY ETF.
COSM has a market cap of $19.01 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, COSM traded as high as $7.44 and as low as $.28.
The top ETF exchange traded funds that COSM belongs to (by Net Assets): VXF.
COSM has underperformed the market in the last year with a return of -17.5%, while the SPY ETF gained +21.0%. In the last 3 month period, COSM fell short of the market, returning -52.3%, while SPY returned +6.7%. However, in the most recent 2 weeks COSM has outperformed the stock market by returning +3.7%, while SPY returned +1.0%.
COSM support price is $.47 and resistance is $.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COSM shares will trade within this expected range on the day.